WO2008006117A3 - Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures - Google Patents
Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures Download PDFInfo
- Publication number
- WO2008006117A3 WO2008006117A3 PCT/US2007/073089 US2007073089W WO2008006117A3 WO 2008006117 A3 WO2008006117 A3 WO 2008006117A3 US 2007073089 W US2007073089 W US 2007073089W WO 2008006117 A3 WO2008006117 A3 WO 2008006117A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- outcome
- improving
- preventing
- postponing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/307,902 US20100093829A1 (en) | 2006-07-07 | 2007-07-09 | Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
CA 2692430 CA2692430A1 (en) | 2006-07-07 | 2007-07-09 | Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81955506P | 2006-07-07 | 2006-07-07 | |
US60/819,555 | 2006-07-07 | ||
US84749306P | 2006-09-27 | 2006-09-27 | |
US60/847,493 | 2006-09-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008006117A2 WO2008006117A2 (en) | 2008-01-10 |
WO2008006117A3 true WO2008006117A3 (en) | 2008-11-20 |
Family
ID=38895521
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/073092 WO2008006118A2 (en) | 2006-07-07 | 2007-07-09 | Novel regimens for treating diseases and disorders |
PCT/US2007/073067 WO2008006106A2 (en) | 2006-07-07 | 2007-07-09 | Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
PCT/US2007/073089 WO2008006117A2 (en) | 2006-07-07 | 2007-07-09 | Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/073092 WO2008006118A2 (en) | 2006-07-07 | 2007-07-09 | Novel regimens for treating diseases and disorders |
PCT/US2007/073067 WO2008006106A2 (en) | 2006-07-07 | 2007-07-09 | Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
Country Status (3)
Country | Link |
---|---|
US (6) | US20080019975A1 (en) |
CA (3) | CA2692428A1 (en) |
WO (3) | WO2008006118A2 (en) |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE45976E1 (en) | 1999-02-24 | 2016-04-19 | Tact Ip, Llc | Methods of inhibiting the action of TNF for neurological conditions by administering etanercept intrathecally |
US6982089B2 (en) * | 1999-02-24 | 2006-01-03 | Tact Ip, Llc | Cytokine antagonists for neurological and neuropsychiatric disorders |
US8119127B2 (en) | 1999-02-24 | 2012-02-21 | Tact Ip, Llc | Cytokine antagonists for neurological and neuropsychiatric disorders |
US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US8895540B2 (en) | 2003-11-26 | 2014-11-25 | DePuy Synthes Products, LLC | Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
GB0414054D0 (en) | 2004-06-23 | 2004-07-28 | Owen Mumford Ltd | Improvements relating to automatic injection devices |
US8236306B2 (en) | 2004-12-18 | 2012-08-07 | Edward Lewis Tobinick | Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers |
AU2007269791B2 (en) * | 2006-06-30 | 2013-10-03 | Abbvie Biotechnology Ltd | Automatic injection device |
WO2008006118A2 (en) * | 2006-07-07 | 2008-01-10 | Bioassets Development Corporation | Novel regimens for treating diseases and disorders |
US20080097229A1 (en) * | 2006-08-29 | 2008-04-24 | Josee Roy | Hygroscopic treatment for degenerating discs |
US20080161929A1 (en) | 2006-12-29 | 2008-07-03 | Mccormack Bruce | Cervical distraction device |
US20100233137A1 (en) * | 2007-02-27 | 2010-09-16 | Lanx, Inc. | Compositions and Methods for Modification of Target Cells and to Their Uses Thereof |
EP2056838B1 (en) | 2007-02-28 | 2013-09-25 | Merck Sharp & Dohme Corp. | Combination therapy for treatment of immune disorders |
WO2008151119A2 (en) * | 2007-06-01 | 2008-12-11 | Lanx, Llc | Compositions and methods for use of scar tissue in repair of weight bearing surfaces |
US8092541B2 (en) * | 2007-08-03 | 2012-01-10 | Warsaw Orthopedic, Inc. | Method of using an anti-growth matrix as a barrier for cell attachment and osteo-inductive factors |
US20090162351A1 (en) * | 2007-12-21 | 2009-06-25 | Depuy Spine, Inc. | Transdiscal administration of inhibitors of p38 MAP kinase |
US8986696B2 (en) * | 2007-12-21 | 2015-03-24 | Depuy Mitek, Inc. | Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints |
US9005288B2 (en) | 2008-01-09 | 2015-04-14 | Providence Medical Techonlogy, Inc. | Methods and apparatus for accessing and treating the facet joint |
CN103271761B (en) | 2008-01-14 | 2015-10-28 | 康文图斯整形外科公司 | For the apparatus and method of fracture repair |
WO2009105606A1 (en) * | 2008-02-21 | 2009-08-27 | Lanx, Llc | Compositions and methods for use of scar tissue in repair of weight bearing surfaces |
US20090263456A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Methods and Compositions for Reducing Preventing and Treating Adhesives |
US9072727B2 (en) * | 2008-04-18 | 2015-07-07 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of degenerative disc disease |
US20090264489A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation |
US20090263443A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedics, Inc. | Methods for treating post-operative effects such as spasticity and shivering with clondine |
WO2010030994A2 (en) | 2008-06-06 | 2010-03-18 | Providence Medical Technology, Inc. | Cervical distraction/implant delivery device |
US8361152B2 (en) | 2008-06-06 | 2013-01-29 | Providence Medical Technology, Inc. | Facet joint implants and delivery tools |
US11224521B2 (en) | 2008-06-06 | 2022-01-18 | Providence Medical Technology, Inc. | Cervical distraction/implant delivery device |
US8267966B2 (en) | 2008-06-06 | 2012-09-18 | Providence Medical Technology, Inc. | Facet joint implants and delivery tools |
US9381049B2 (en) | 2008-06-06 | 2016-07-05 | Providence Medical Technology, Inc. | Composite spinal facet implant with textured surfaces |
US9333086B2 (en) | 2008-06-06 | 2016-05-10 | Providence Medical Technology, Inc. | Spinal facet cage implant |
WO2009148619A2 (en) | 2008-06-06 | 2009-12-10 | Providence Medical Technology, Inc. | Facet joint implants and delivery tools |
US9492375B2 (en) | 2008-07-23 | 2016-11-15 | Warsaw Orthopedic, Inc. | Foam carrier for bone grafting |
AU2009288088B2 (en) | 2008-09-03 | 2014-12-04 | Nono Inc. | Agents and methods for treatment of pain |
US9149319B2 (en) * | 2008-09-23 | 2015-10-06 | Lanx, Llc | Methods and compositions for stabilization of a vertebra |
JP5529874B2 (en) * | 2008-09-25 | 2014-06-25 | インヴィーヴォ セラプーティクス コーポレーション | Therapeutic agents that can control local release, used for spinal cord injury, inflammation and immune disorders |
US20100098746A1 (en) * | 2008-10-20 | 2010-04-22 | Warsaw Orthopedic, Inc. | Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone |
US20100228097A1 (en) * | 2009-03-04 | 2010-09-09 | Warsaw Orthopedic, Inc. | Methods and compositions to diagnose pain |
US20100226959A1 (en) * | 2009-03-04 | 2010-09-09 | Warsaw Orthopedic, Inc. | Matrix that prolongs growth factor release |
MX2011011541A (en) * | 2009-04-29 | 2012-02-28 | Abbott Biotech Ltd | Automatic injection device. |
EP2429503A1 (en) * | 2009-05-13 | 2012-03-21 | Protein Delivery Solutions, LLC | Pharmaceutical system for trans-membrane delivery |
US8653029B2 (en) | 2009-07-30 | 2014-02-18 | Warsaw Orthopedic, Inc. | Flowable paste and putty bone void filler |
US8597192B2 (en) | 2009-10-30 | 2013-12-03 | Warsaw Orthopedic, Inc. | Ultrasonic devices and methods to diagnose pain generators |
NZ627052A (en) * | 2009-12-15 | 2015-12-24 | Abbvie Biotechnology Ltd | Improved firing button for automatic injection device |
WO2011088172A1 (en) | 2010-01-15 | 2011-07-21 | Brenzel Michael P | Rotary-rigid orthopaedic rod |
EP2523616B1 (en) | 2010-01-20 | 2019-04-17 | Conventus Orthopaedics, Inc. | Apparatus for bone access and cavity preparation |
US8758791B2 (en) * | 2010-01-26 | 2014-06-24 | Warsaw Orthopedic, Inc. | Highly compression resistant matrix with porous skeleton |
US8475824B2 (en) * | 2010-01-26 | 2013-07-02 | Warsaw Orthopedic, Inc. | Resorbable matrix having elongated particles |
JP5907898B2 (en) * | 2010-03-08 | 2016-04-26 | コンベンタス オーソピディックス, インコーポレイテッド | Apparatus and method for bone repair |
CN103002824B (en) | 2010-03-08 | 2015-07-29 | 康文图斯整形外科公司 | For the device and method of fixing bone implant |
US9526600B2 (en) * | 2010-07-20 | 2016-12-27 | Warsaw Orthopedic, Inc. | Biodegradable stents and methods for treating periodontal disease |
WO2012103141A1 (en) | 2011-01-24 | 2012-08-02 | Abbott Biotechnology Ltd. | Automatic injection devices having overmolded gripping surfaces |
US9060978B2 (en) * | 2011-01-24 | 2015-06-23 | Warsaw Orthopedic, Inc. | Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist |
US9717779B2 (en) | 2011-01-31 | 2017-08-01 | Warsaw Orthopedic, Inc. | Implantable matrix having optimum ligand concentrations |
US9970057B2 (en) | 2011-05-06 | 2018-05-15 | Albert Einstein College Of Medicine, Inc. | Human invasion signature for prognosis of metastatic risk |
WO2012154654A2 (en) * | 2011-05-06 | 2012-11-15 | Baylor College Of Medicine | Methods for imaging bone precursor cells using dual-labeled imaging agents to detect mmp-9 positive cells |
US20130297023A1 (en) * | 2012-05-07 | 2013-11-07 | Hee-Jeong Im Sampen | Methods and Devices For Treating Intervertebral Disc Disease |
WO2013177432A1 (en) * | 2012-05-23 | 2013-11-28 | The University Of Chicago | Methods of treating obesity |
USD732667S1 (en) | 2012-10-23 | 2015-06-23 | Providence Medical Technology, Inc. | Cage spinal implant |
USD745156S1 (en) | 2012-10-23 | 2015-12-08 | Providence Medical Technology, Inc. | Spinal implant |
CN105939677A (en) | 2013-12-12 | 2016-09-14 | 康文图斯整形外科公司 | Tissue displacement tools and methods |
US20150241445A1 (en) * | 2014-02-24 | 2015-08-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods of prognosis and classification for recovery from surgical trauma |
US9867641B2 (en) | 2014-05-15 | 2018-01-16 | Brahm Holdings, Llc | Spinal graft |
AU2015267061B9 (en) | 2014-05-28 | 2020-08-13 | Providence Medical Technology, Inc. | Lateral mass fixation system |
US11461848B1 (en) | 2015-01-14 | 2022-10-04 | Alchemy Logic Systems, Inc. | Methods of obtaining high accuracy impairment ratings and to assist data integrity in the impairment rating process |
US10898590B2 (en) * | 2015-09-21 | 2021-01-26 | Kolon Life Science, Inc. | Method for delivery of biological molecule to nervous tissue |
USD841165S1 (en) | 2015-10-13 | 2019-02-19 | Providence Medical Technology, Inc. | Cervical cage |
WO2017066475A1 (en) | 2015-10-13 | 2017-04-20 | Providence Medical Technology, Inc. | Spinal joint implant delivery device and system |
CN105497017B (en) * | 2015-11-20 | 2018-02-23 | 厦门大学 | The pharmaceutical applications of wedelolactone |
EP3474785A4 (en) | 2016-06-28 | 2020-03-04 | Providence Medical Technology, Inc. | Spinal implant and methods of using the same |
USD887552S1 (en) | 2016-07-01 | 2020-06-16 | Providence Medical Technology, Inc. | Cervical cage |
US11853973B1 (en) | 2016-07-26 | 2023-12-26 | Alchemy Logic Systems, Inc. | Method of and system for executing an impairment repair process |
US11854700B1 (en) | 2016-12-06 | 2023-12-26 | Alchemy Logic Systems, Inc. | Method of and system for determining a highly accurate and objective maximum medical improvement status and dating assignment |
EP3624708A1 (en) | 2017-05-19 | 2020-03-25 | Providence Medical Technology, Inc. | Spinal fixation access and delivery system |
US11571429B2 (en) * | 2017-05-23 | 2023-02-07 | Upexmed Co. Ltd. | Method and compounds for treating peripheral neuropathy |
US20180338929A1 (en) * | 2017-05-23 | 2018-11-29 | Soon Kap Hahn | Method and Compounds for Treating Peripheral Neuropathy |
EP3631450B1 (en) | 2017-05-29 | 2022-11-23 | Charité - Universitätsmedizin Berlin | Cd8 t cell subsets as a biomarker for predicting non-fusion after spinal fusion surgery |
US10918426B2 (en) | 2017-07-04 | 2021-02-16 | Conventus Orthopaedics, Inc. | Apparatus and methods for treatment of a bone |
JP2020526554A (en) * | 2017-07-13 | 2020-08-31 | ユニバーシティ オブ マイアミ | How to manage pain |
US11793836B2 (en) * | 2017-09-27 | 2023-10-24 | Inmune Bio Inc | Method for treating complications related to acute or chronic hyperglycemia |
CN107736956B (en) * | 2017-09-30 | 2023-07-21 | 四川大学华西医院 | Artificial intelligent cervical intervertebral disc capable of recording pressure and motion |
US11464804B1 (en) * | 2017-11-15 | 2022-10-11 | Enrico Stazzone | Intrathecal multifactorial infusion of heterogeneous autologous cell therapy |
US11648128B2 (en) | 2018-01-04 | 2023-05-16 | Providence Medical Technology, Inc. | Facet screw and delivery device |
US11625687B1 (en) | 2018-10-16 | 2023-04-11 | Alchemy Logic Systems Inc. | Method of and system for parity repair for functional limitation determination and injury profile reports in worker's compensation cases |
USD933230S1 (en) | 2019-04-15 | 2021-10-12 | Providence Medical Technology, Inc. | Cervical cage |
USD911525S1 (en) | 2019-06-21 | 2021-02-23 | Providence Medical Technology, Inc. | Spinal cage |
US11848109B1 (en) | 2019-07-29 | 2023-12-19 | Alchemy Logic Systems, Inc. | System and method of determining financial loss for worker's compensation injury claims |
USD945621S1 (en) | 2020-02-27 | 2022-03-08 | Providence Medical Technology, Inc. | Spinal cage |
WO2022235932A1 (en) * | 2021-05-05 | 2022-11-10 | Board Of Regents, The University Of Texas System | Methods and compositions for treatment of neuropathic pain using stat3 inhibitors |
WO2023244864A1 (en) * | 2022-06-17 | 2023-12-21 | Spencer Spence | Ozone therapeutic treatment apparatus and method of use to treat a treatment location |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010026801A1 (en) * | 1999-02-24 | 2001-10-04 | Tobinick Edward L. | Cytokine antagonists for the treatment of localized disorders |
US6340369B1 (en) * | 1999-08-13 | 2002-01-22 | Bret A. Ferree | Treating degenerative disc disease with harvested disc cells and analogues of the extracellular matrix |
US20040022864A1 (en) * | 2002-08-05 | 2004-02-05 | Toby Freyman | Methods of delivering therapeutic agents |
US7344716B2 (en) * | 2003-05-13 | 2008-03-18 | Depuy Spine, Inc. | Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925833A (en) * | 1983-12-29 | 1990-05-15 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis |
US4666897A (en) * | 1983-12-29 | 1987-05-19 | Research Foundation Of State University | Inhibition of mammalian collagenolytic enzymes by tetracyclines |
IL85035A0 (en) * | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
US6586388B2 (en) * | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
US5605690A (en) * | 1989-09-05 | 1997-02-25 | Immunex Corporation | Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor |
US5395760A (en) * | 1989-09-05 | 1995-03-07 | Immunex Corporation | DNA encoding tumor necrosis factor-α and -β receptors |
NZ235148A (en) * | 1989-09-05 | 1991-12-23 | Immunex Corp | Tumour necrosis factor receptor protein and dna sequences |
US5129900B1 (en) * | 1990-07-24 | 1998-12-29 | Acromed Corp | Spinal column retaining method and apparatus |
JP2818056B2 (en) * | 1990-09-07 | 1998-10-30 | 森永乳業株式会社 | Antimicrobial peptides and antimicrobial agents |
US6284471B1 (en) * | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
US6277969B1 (en) * | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
US7192584B2 (en) * | 1991-03-18 | 2007-03-20 | Centocor, Inc. | Methods of treating psoriasis with anti-TNF antibodies |
US5763446A (en) * | 1992-03-26 | 1998-06-09 | University Of Southern California | Use of pentoxifylline and other tumor necrosis factor blockers for the treatment of aids-associated optic neuropathy and other central nervous system diseases |
MX9301943A (en) * | 1992-04-02 | 1994-08-31 | Smithkline Beecham Corp | COMPOUNDS. |
US6248110B1 (en) * | 1994-01-26 | 2001-06-19 | Kyphon, Inc. | Systems and methods for treating fractured or diseased bone using expandable bodies |
US5574022A (en) * | 1994-04-14 | 1996-11-12 | The Center For Innovative Technology | Method of attenuating physical damage to the spinal cord |
FR2722980B1 (en) * | 1994-07-26 | 1996-09-27 | Samani Jacques | INTERTEPINOUS VERTEBRAL IMPLANT |
US6245072B1 (en) * | 1995-03-27 | 2001-06-12 | Sdgi Holdings, Inc. | Methods and instruments for interbody fusion |
US5782919A (en) * | 1995-03-27 | 1998-07-21 | Sdgi Holdings, Inc. | Interbody fusion device and method for restoration of normal spinal anatomy |
US5643915A (en) * | 1995-06-06 | 1997-07-01 | Andrulis Pharmaceuticals Corp. | Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapies |
US6406867B1 (en) * | 1996-08-16 | 2002-06-18 | Human Genome Sciences, Inc. | Antibody to human endokine alpha and methods of use |
US6812327B1 (en) * | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
US6869938B1 (en) * | 1997-06-17 | 2005-03-22 | Fziomed, Inc. | Compositions of polyacids and polyethers and methods for their use in reducing adhesions |
US6136308A (en) * | 1997-09-12 | 2000-10-24 | Vasogen Ireland Limited | Treatment of stress and preconditioning against stress |
WO1999018792A1 (en) * | 1997-10-10 | 1999-04-22 | Johns Hopkins University | Gene delivery compositions and methods |
WO1999057303A1 (en) * | 1998-05-07 | 1999-11-11 | University Of Maryland, Baltimore | A method for diagnosing and treating chronic pelvic pain syndrome |
US6152943A (en) * | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
US7115557B2 (en) * | 1998-09-25 | 2006-10-03 | Sciaticon Ab | Use of certain drugs for treating nerve root injury |
US7906481B2 (en) * | 1998-09-25 | 2011-03-15 | Sciaticon Ab | Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pulposus |
US7811990B2 (en) * | 1998-09-25 | 2010-10-12 | Sciaticon Ab | Soluble cytokine receptors TNF-α blocking antibodies for treating spinal disorders mediated by nucleus pulposus |
ES2242600T3 (en) * | 1999-02-04 | 2005-11-16 | Sdgi Holdings, Inc. | COMPOSITIONS OF OSTEOGENIC PASTE AND ITS USES. |
US7214658B2 (en) * | 2004-07-06 | 2007-05-08 | Tact Ip, Llc | Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection |
US6423321B2 (en) * | 1999-02-24 | 2002-07-23 | Edward L. Tobinick | Cytokine antagonists for the treatment of sensorineural hearing loss |
US8119127B2 (en) * | 1999-02-24 | 2012-02-21 | Tact Ip, Llc | Cytokine antagonists for neurological and neuropsychiatric disorders |
US6177077B1 (en) * | 1999-02-24 | 2001-01-23 | Edward L. Tobinick | TNT inhibitors for the treatment of neurological disorders |
US20030007972A1 (en) * | 1999-02-24 | 2003-01-09 | Edward Tobinick | Cytokine antagonists and other biologics for the treatment of bone metastases |
US6015557A (en) * | 1999-02-24 | 2000-01-18 | Tobinick; Edward L. | Tumor necrosis factor antagonists for the treatment of neurological disorders |
US20030113318A1 (en) * | 1999-02-24 | 2003-06-19 | Tobinick Edward Lewis | TNF inhibition for the treatment of pre-menstrual syndrome and primary dysmenorrhea |
US6379666B1 (en) * | 1999-02-24 | 2002-04-30 | Edward L. Tobinick | TNF inhibitors for the treatment of neurological, retinal and muscular disorders |
US6982089B2 (en) * | 1999-02-24 | 2006-01-03 | Tact Ip, Llc | Cytokine antagonists for neurological and neuropsychiatric disorders |
US6245108B1 (en) * | 1999-02-25 | 2001-06-12 | Spineco | Spinal fusion implant |
AU6168699A (en) * | 1999-03-24 | 2000-10-09 | Parallax Medical, Inc. | Non-compliant system for delivery of implant material |
JP4247519B2 (en) * | 1999-08-18 | 2009-04-02 | イントリンジック セラピューティックス インコーポレイテッド | Apparatus and method for nucleus augmentation and retention |
US6592625B2 (en) * | 1999-10-20 | 2003-07-15 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US6533817B1 (en) * | 2000-06-05 | 2003-03-18 | Raymedica, Inc. | Packaged, partially hydrated prosthetic disc nucleus |
US20050249735A1 (en) * | 2000-08-07 | 2005-11-10 | Centocor, Inc. | Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factor |
US20060018907A1 (en) * | 2000-08-07 | 2006-01-26 | Centocor, Inc. | Anti-TNF antibodies and peptides of human tumor necrosis factor |
US6773723B1 (en) * | 2000-08-30 | 2004-08-10 | Depuy Acromed, Inc. | Collagen/polysaccharide bilayer matrix |
US6579319B2 (en) * | 2000-11-29 | 2003-06-17 | Medicinelodge, Inc. | Facet joint replacement |
US6375659B1 (en) * | 2001-02-20 | 2002-04-23 | Vita Licensing, Inc. | Method for delivery of biocompatible material |
WO2002068962A2 (en) * | 2001-02-21 | 2002-09-06 | Stryker Corporation | Determining cartilage degeneration and aging using bone morphogenic proteins |
US6989031B2 (en) * | 2001-04-02 | 2006-01-24 | Sdgi Holdings, Inc. | Hemi-interbody spinal implant manufactured from a major long bone ring or a bone composite |
US6569201B2 (en) * | 2001-09-28 | 2003-05-27 | Depuy Acromed, Inc. | Hybrid composite interbody fusion device |
EP1448089A4 (en) * | 2001-11-01 | 2008-06-04 | Spine Wave Inc | Devices and methods for the restoration of a spinal disc |
US6582439B1 (en) * | 2001-12-28 | 2003-06-24 | Yacmur Llc | Vertebroplasty system |
US6740118B2 (en) * | 2002-01-09 | 2004-05-25 | Sdgi Holdings, Inc. | Intervertebral prosthetic joint |
US6726720B2 (en) * | 2002-03-27 | 2004-04-27 | Depuy Spine, Inc. | Modular disc prosthesis |
US7004944B2 (en) * | 2002-07-16 | 2006-02-28 | Sdgi Holdings, Inc. | Bone plate fastener retaining mechanisms and methods |
US7588573B2 (en) * | 2002-09-23 | 2009-09-15 | Warsaw Orthopedic, Inc. | Expansion tool for adjustable spinal implant |
US6899735B2 (en) * | 2002-10-02 | 2005-05-31 | Sdgi Holdings, Inc. | Modular intervertebral prosthesis system |
AU2003297849A1 (en) * | 2002-12-17 | 2004-07-29 | Bristol-Myers Squibb Company | Anti-inflammatory coating for implantable medical devices |
BRPI0410697A (en) * | 2003-05-02 | 2006-06-20 | Univ Yale | dynamic spine stabilizer and method |
US8361467B2 (en) * | 2003-07-30 | 2013-01-29 | Depuy Spine, Inc. | Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints |
US20050095246A1 (en) * | 2003-10-24 | 2005-05-05 | Medtronic, Inc. | Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
US8895540B2 (en) * | 2003-11-26 | 2014-11-25 | DePuy Synthes Products, LLC | Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
US7226250B2 (en) * | 2003-12-22 | 2007-06-05 | Hayes Lemmerz International, Inc. | Tool and method for forming a lug hole |
TWI439284B (en) * | 2004-04-09 | 2014-06-01 | Abbvie Biotechnology Ltd | Multiple-variable dose regimen for treating tnfα-related disorders |
US7051451B2 (en) * | 2004-04-22 | 2006-05-30 | Archus Orthopedics, Inc. | Facet joint prosthesis measurement and implant tools |
US7261738B2 (en) * | 2004-06-30 | 2007-08-28 | Depuy Spine, Inc. | C-shaped disc prosthesis |
US20060046961A1 (en) * | 2004-09-02 | 2006-03-02 | Mckay William F | Controlled and directed local delivery of anti-inflammatory compositions |
US20060046960A1 (en) * | 2004-09-02 | 2006-03-02 | Mckay William F | Controlled and directed local delivery of anti-inflammatory compositions |
US7023188B1 (en) * | 2004-09-10 | 2006-04-04 | Semiconductor Components Industries, L.L.C. | Method of forming a multi-phase power supply controller |
EP1937187A4 (en) * | 2005-10-19 | 2012-05-30 | Entpr Inc A | Curable bone substitute |
US8197545B2 (en) * | 2005-10-27 | 2012-06-12 | Depuy Spine, Inc. | Nucleus augmentation delivery device and technique |
WO2008006118A2 (en) * | 2006-07-07 | 2008-01-10 | Bioassets Development Corporation | Novel regimens for treating diseases and disorders |
-
2007
- 2007-07-09 WO PCT/US2007/073092 patent/WO2008006118A2/en active Application Filing
- 2007-07-09 US US11/775,206 patent/US20080019975A1/en not_active Abandoned
- 2007-07-09 CA CA 2692428 patent/CA2692428A1/en not_active Abandoned
- 2007-07-09 WO PCT/US2007/073067 patent/WO2008006106A2/en active Application Filing
- 2007-07-09 US US12/307,900 patent/US20100040609A1/en not_active Abandoned
- 2007-07-09 US US12/307,907 patent/US20100047235A1/en not_active Abandoned
- 2007-07-09 WO PCT/US2007/073089 patent/WO2008006117A2/en active Application Filing
- 2007-07-09 US US11/775,189 patent/US20080019970A1/en not_active Abandoned
- 2007-07-09 US US12/307,902 patent/US20100093829A1/en not_active Abandoned
- 2007-07-09 US US11/775,031 patent/US20080019969A1/en not_active Abandoned
- 2007-07-09 CA CA2697784A patent/CA2697784A1/en not_active Abandoned
- 2007-07-09 CA CA 2692430 patent/CA2692430A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010026801A1 (en) * | 1999-02-24 | 2001-10-04 | Tobinick Edward L. | Cytokine antagonists for the treatment of localized disorders |
US6340369B1 (en) * | 1999-08-13 | 2002-01-22 | Bret A. Ferree | Treating degenerative disc disease with harvested disc cells and analogues of the extracellular matrix |
US20040022864A1 (en) * | 2002-08-05 | 2004-02-05 | Toby Freyman | Methods of delivering therapeutic agents |
US7344716B2 (en) * | 2003-05-13 | 2008-03-18 | Depuy Spine, Inc. | Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
Also Published As
Publication number | Publication date |
---|---|
WO2008006118A2 (en) | 2008-01-10 |
CA2692430A1 (en) | 2008-01-10 |
WO2008006118A3 (en) | 2008-11-20 |
US20080019970A1 (en) | 2008-01-24 |
US20080019975A1 (en) | 2008-01-24 |
US20100040609A1 (en) | 2010-02-18 |
WO2008006106A3 (en) | 2008-12-18 |
US20100047235A1 (en) | 2010-02-25 |
CA2697784A1 (en) | 2008-01-10 |
US20100093829A1 (en) | 2010-04-15 |
WO2008006117A2 (en) | 2008-01-10 |
US20080019969A1 (en) | 2008-01-24 |
CA2692428A1 (en) | 2008-01-10 |
WO2008006106A2 (en) | 2008-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008006117A3 (en) | Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures | |
WO2012027065A3 (en) | Combination therapy for treatment of disease | |
CL2017003288A1 (en) | Methods to treat or prevent cholesterol-related diseases (divisional application 201303214) | |
MX337081B (en) | Anti-nr10 antibody and use thereof. | |
UA96124C2 (en) | Pharmaceutical foam formulation copmprising imiquimod | |
WO2012040527A3 (en) | Deubiquitinase inhibitors and methods for use of the same | |
AR091876A1 (en) | PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
BR112013008140A2 (en) | "imidazotriazinone compounds". | |
BR112013004750A2 (en) | quinoline and quinoxaline derivatives as kinase inhibitors | |
WO2006085906A3 (en) | Method for the direct detection of diagnostic rna | |
WO2008051599A3 (en) | Combination therapies for treating alzheimer's disease using i. a. dimebon and dolepezil | |
NO20090593L (en) | Modulators of pharmacokinetic properties of therapeutics | |
WO2012047587A3 (en) | Mdm2 inhibitors for treatment of ocular conditions | |
WO2007106317A3 (en) | Pharmaceutical combinations of hcv-protease and -ires inhibitors | |
WO2012174338A3 (en) | Method of selecting therapeutic indications | |
UA99284C2 (en) | P70 s6 kinase inhibitors | |
WO2007050793A3 (en) | Methods and compositions for the treatment of marfan syndrome and associated disorders | |
WO2008083160A3 (en) | Methods and compositions for therapeutic treatment | |
WO2011063048A3 (en) | Urinary triaosylceramide (gb3) as a marker of cardiac disease | |
WO2008060618A3 (en) | Use of genetic determinants in cardiovascular risk assessment | |
WO2009067543A3 (en) | Treatment of histone deacetylase mediated disorders | |
NO20083751L (en) | Methods for the treatment of cognitive and other diseases | |
MX2010002559A (en) | Compositions and methods for treating immunological and inflammatory diseases and disorders. | |
UA105827C2 (en) | Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR | |
WO2008022263A3 (en) | Methods for lymph system imaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07799426 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07799426 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12307902 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2692430 Country of ref document: CA |